Upstream Bioprocessing Update

CELL AND GENE THERAPY INSIGHTS

March 2019

Upstream Bioprocessing Update

Download PDF

Editorial

Manufacturing of genetically modified autologous T cells: key considerations for process development

Manufacturing of genetically modified autologous T cells: key considerations for process development

Mamta Kalra, Ali Mohamed

Expert Insight

Bioprocessing & biological challenges of large-scale red blood cell production from pluripotent stem cells: important factors to consider

Bioprocessing & biological challenges of large-scale red blood cell production from pluripotent stem cells: important factors to consider

Steve Oh, Jaichandran Sivalingam

Commentary

Creating a cell-friendly microenvironment to enhance cell culture efficiency

Creating a cell-friendly microenvironment to enhance cell culture efficiency

Ou Wang, Yuguo Lei

Key success criteria and factors for delivering scalable cell therapy upstream bioprocesses

Key success criteria and factors for delivering scalable cell therapy upstream bioprocesses

Podcast

Determining the optimal culture system for your scale up strategy

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover

Interview

Challenges in upstream bioprocess development for viral vector production

Challenges in upstream bioprocess development for viral vector production

Ankita Desai, Philipp Nold

Determining the optimal culture system for your scale up strategy

Determining the optimal culture system for your scale up strategy

Marco Koppe, Clive Glover

A 3D vision for the future of tissue engineering

A 3D vision for the future of tissue engineering

Suwan N Jayasinghe